2022. Antihypertensive & Anti-diabetic Activity of Simvastatin & Reserpine in Ang-II Induced Hypertension and STZ Induced Type-II Diabetes Mellitus. International Journal of Pharmacy and Life Sciences. 13, 4 (Apr. 2022), 27–34.